<?xml version="1.0" encoding="UTF-8"?>
<ref id="B36-marinedrugs-18-00228">
 <label>36.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Jodele</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Laskin</surname>
    <given-names>B.L.</given-names>
   </name>
   <name>
    <surname>Dandoy</surname>
    <given-names>C.E.</given-names>
   </name>
   <name>
    <surname>Myers</surname>
    <given-names>K.C.</given-names>
   </name>
   <name>
    <surname>El-Bietar</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Davies</surname>
    <given-names>S.M.</given-names>
   </name>
   <name>
    <surname>Goebel</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Dixon</surname>
    <given-names>B.P.</given-names>
   </name>
  </person-group>
  <article-title>A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury</article-title>
  <source>Blood Rev.</source>
  <year>2015</year>
  <volume>29</volume>
  <fpage>191</fpage>
  <lpage>204</lpage>
  <pub-id pub-id-type="doi">10.1016/j.blre.2014.11.001</pub-id>
  <?supplied-pmid 25483393?>
  <pub-id pub-id-type="pmid">25483393</pub-id>
 </element-citation>
</ref>
